Neblett Beard and ArsenaultRichard J. Arsenault, Neblett, Beard & Arsenault’s senior and founding partner, will be presenting information on Actos at the American Association for Justice’s Actos Teleseminar on September 8 at 2:00pm-3:30pm  ET.

According to an FDA warning, prolonged use of Actos may cause an increased risk of developing bladder cancer.

The seminar will provide an in-depth look at the FDA’s recent update to its health warning regarding Actos, a Type-2 diabetes drug. Through exploration of Actos’ history, as well as recent studies and regulatory action, the faculty will delve into information and strategies that will help plaintiff lawyers understand how to proceed with current litigation.

Arsenault and his firm have filed several lawsuits on behalf of Actos victims who have developed bladder cancer.

To view the agenda, faculty and to register, visit